CISA published advisory ICSMA-18-219-02 (Update A) on August 7, 2018, covering the Medtronic MMT-500 and MMT-503 remote controllers and the insulin pumps they pair with: pump models MMT-508, MMT-511, MMT-512/712, MMT-515/715, MMT-522/722, MMT-523/723, the MiniMed 530G (MMT-551/751) and the MiniMed Veo (MMT-554/754). Billy Rios, Jesse Young and Jonathan Butts of Whitescope LLC reported the issues.
CVE-2018-10634 (CWE-319, CVSS v3 4.8) covers the radio link: communications between the pump and wireless accessories go out in cleartext, so a skilled attacker can capture them and extract data such as device serial numbers. CVE-2018-14781 (CWE-294, CVSS v3 5.3) is the one with clinical weight. With a remote paired and the easy bolus and remote bolus options turned on, an attacker can capture the remote's transmissions and replay them to trigger an insulin bolus.
Several conditions narrow the risk. The remote option is off by default, the attacker has to be in radio range, and the pump gives a physical alert that lets the user suspend the bolus.
Medtronic chose withdrawal over a fix. It directed all users to stop using the remote controllers, disable the remote option on the pump and return the remotes, and said it would send letters to patients who may still be using them.
A therapy command that can be replayed off the air is a design defect, and retiring the accessory was the honest answer for hardware that cannot be updated in the field.